Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New Research Results: ’Heart Jacket’ Shown to Be Effective Treatment for Heart Failure

11.11.2004


SLU Cardiologist Was First in Missouri to Investigate the Device



The concept is simple: to halt deterioration of the heart muscle, wrap it in a mesh-like net to prevent further enlargement in patients with heart failure. It’s like a jacket for the heart.

New research results from Saint Louis University and other institutions across the country found the "heart jacket" technique helped patients feel better and reduced the likelihood that they would need a heart transplant. "There was a clear improvement in the size and shape of the heart, returning it to a more normal configuration," says Paul Hauptman, M.D., a SLUCare cardiologist and associate professor at Saint Louis University School of Medicine. "It’s a potentially revolutionary approach."


Heart failure is a condition in which the heart can’t circulate enough blood to meet the needs of the body. Patients who have the problem typically have enlarged hearts that continue to get larger and weaker as the condition progresses. The CorCap Cardiac Support Device is an investigational, mesh-like heart "jacket" that is slipped around the heart during chest surgery and stitched in place to prevent any further enlargement. It is made from a custom knitted polyester fabric and is intended to be an adjunctive therapy for patients with moderate to severe heart failure.

Saint Louis University’s Dr. Hauptman was the only investigator in Missouri involved in this clinical trial. He led the school’s clinical trial in this area, which was sponsored by Acorn Cardiovascular of St. Paul, Minn., the manufacturer of the device. The clinical trial involved 300 patients at 28 U.S. hospitals and one in Canada. Preliminary results found that the 148 patients randomized to receive the device showed significant improvement. The findings were presented this week at the American Heart Association Meeting in New Orleans.

Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first M.D. degree west of the Mississippi River. Saint Louis University School of Medicine is a pioneer in geriatric medicine, organ transplantation, chronic disease prevention, cardiovascular disease, neurosciences and vaccine research, among others. The School of Medicine trains physicians and biomedical scientists, conducts medical research, and provides health services on a local, national and international level.

Joe Muehlenkamp | EurekAlert!
Further information:
http://www.slu.edu

More articles from Health and Medicine:

nachricht Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering

nachricht New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>